Dr. Clive S. Zent, MD
- Medicare services, 2024
- 415
- Medicare patients, 2024
- 131
- Part D claims, 2024
- 355
- Publications
- 183
- Clinical trials
- 6
- Practice address
- 601 Elmwood Ave, Rochester, NY 14642
- Practice phone
- Call (585) 275-2121
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Zent's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Clive S. Zent is a hematology (internal medicine) physician in Rochester, New York
Dr. Zent practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.
Dr. Zent's NPI, 1225015662, was assigned on December 28, 2005. Dr. Zent graduated from University of the Witwatersrand in 1983. Dr. Zent's Minnesota license number on file is 45639.
- NPI
- 1225015662NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7315089828
- NPI enumeration date
- December 28, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (585) 275-2121
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 69
- Medical school graduation
- 1983
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Clive S. Zent practices at Strong Memorial Hospital in Rochester, New York
Dr. Zent's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.
- Strong Memorial Hospital601 Elmwood Ave, Rochester, NY 14642 · Monroe CountyPhone(585) 275-2121
Source: Dmand AI Affiliation Data
Dr. Clive S. Zent is affiliated with 1 site of care and 3 medical groups
Dr. Zent's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Zent to 2 more medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Clive S. Zent's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zent practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Strong Memorial Hospital | Available with a free account |
| +2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Rochester Medical Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Clive S. Zent is one of 139 hematology (internal medicine) physicians in New York
Internal medicine is Dr. Zent's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Zent is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Zent's licenses on file in 4 states: Minnesota, New York, Arkansas and Illinois.
Specialties and state licenses
- Hematology (internal medicine), MinnesotaPrimary
- New York license
- Arkansas license
- Illinois license
Clinical focus
Dmand AI lists chronic anemia, chronic leukemia, lung cancer and lymphoma among the conditions Dr. Zent treats.
Hematology (internal medicine) physicians near Dr. Zent
Counts of hematology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Clive S. Zent billed Medicare for 415 services in 2024
CMS data shows 415 Medicare services from Dr. Zent across 3 procedure codes in 2024, for 131 Medicare patients. Medicare paid $21,313 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Zent's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3062024: 23224%
- Other services
- 2023: 02024: 183
Dr. Zent compared with the New York median for hematology (internal medicine) physicians, 2024
- Dr. Zent
- New York median
- Medicare services
- 415vs 29839% above
- Medicare patients
- 131vs 131Close to median
- Part D claims
- 308vs 1302.4 times
Medians across 121 hematology (internal medicine) physicians in New York with Dmand AI profiles that report each measure.
Dr. Zent's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Zent?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Zent and other hematology (internal medicine) physicians in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Clive S. Zent treated 131 Medicare patients in 2024, average age 74
CMS counts 131 Medicare patients who saw Dr. Zent in 2024. The largest group is 75 to 84, with 57 patients. 69% of them have high blood pressure, and 64% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Zent's median patient age at 73, with 39% women.
Dr. Zent's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Zent's Medicare patients by sex, 2024
- Women4434%
- Men8766%
Chronic conditions among Dr. Zent's Medicare patients, 2024
- High blood pressure69%
- High cholesterol64%
- Arthritis46%
- Chronic kidney disease35%
- Ischemic heart disease30%
- Diabetes29%
- Atrial fibrillation24%
- Anxiety21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Zent's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women39%
- Men60%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Clive S. Zent wrote 355 Medicare Part D claims in 2024
In 2024, Dr. Zent wrote 355 Medicare Part D claims for 75 patients. 8% of them were for generic drugs. CMS names the drug for 308 of them, across 4 drugs with 11 or more claims each, at $4,297,873 in total drug cost. In 2023, CMS named 283 claims across 5 drugs.
Dr. Zent's Part D claims by kind of drug, 2024
- Generic27 claims8%
- Brand-name328 claims92%
Dr. Zent's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2832024: 3089%
Drugs named by CMS: 4 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Clive S. Zent takes part in Medicare
Dr. Zent accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Clive S. Zent has 183 publications on record
Dmand AI links 183 papers to Dr. Zent, published from 2002 to 2024. 2018 was the busiest year, with 11. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Antineoplastic Agents and Antibodies, Monoclonal. Dr. Zent has published most often in Leuk Lymphoma. Dr. Zent's most frequent co-authors are Tait D. Shanafelt, MD, Paul Michael Barr, MD and Timothy George Call, MD.
Dr. Zent's papers by year, 2015 to 2024
Topics Dr. Zent writes about most
- Leukemia, Lymphocytic, Chronic, B-Cell
- Antineoplastic Agents
- Antibodies, Monoclonal
- Rituximab
- Antineoplastic Combined Chemotherapy Protocols
- B-Lymphocytes
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived
Dr. Zent's most frequent co-authors
- Tait D. Shanafelt, MD42 shared papers
- Paul Michael Barr, MD28 shared papers
- Timothy George Call, MD21 shared papers
Recent publications by Dr. Zent
Clin Lymphoma Myeloma Leuk
See who Dr. Zent researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Zent works with, so you can find a warm path to the right hematology (internal medicine) physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Clive S. Zent has worked on 6 clinical trials
Dmand AI links Dr. Zent to 6 clinical trials, 4 of them phase 2 studies. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Hematologic Neoplasms. Mayo Clinic sponsors the most, 4.
Clinical trials with Dr. Zent by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- 4Phase 2: 4 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Zent's trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
- Hematologic Neoplasms
- Leukemia, Lymphoid
Investigators on the most trials with Dr. Zent
- Julie Elizabeth Chang, MD1 shared trial
- Jose Francisco Leis, MD1 shared trial
- Thomas E. Witzig, MD1 shared trial
Recent clinical trials with Dr. Zent
Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia (opens in a new tab)
Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (opens in a new tab)
Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia (opens in a new tab)
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Clive S. Zent received $123 in industry payments from 2016 to 2021
CMS Open Payments shows 2 general payments to Dr. Zent from 2 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $69.
General payments to Dr. Zent by program year, 2016 to 2021
Companies that paid Dr. Zent the most, 2016 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Clive S. Zent has 1 award and honors on record
Dmand AI lists 1 award for Dr. Zent, most recently CMS Stage 1 EHR in 2014.
Awards and honors for Dr. Zent
- 2014
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Clive S. Zent graduated from University of the Witwatersrand
Dr. Zent graduated from University of the Witwatersrand in 1983. Dr. Zent is a member of ASH.
- Medical school
- Board certified in hematology
Source: Dmand AI Professional Profile Data
Dr. Clive S. Zent accepts plans from 19 insurance carriers
Dr. Zent is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Excellus BlueCross BlueShield
- United Healthcare
- HCSC
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- Blue Cross Blue Shield of Michigan
- +11 more carriersWith a free account
Plan types Dr. Zent accepts, by number of carriers
- PPO12
- Medicare9
- HMO8
- EPO6
- POS5
- Medicaid3
Source: Dmand AI Insurance Network Data
Sources for Dr. Clive S. Zent's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Clive S. Zent
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Clive S. Zent's NPI number?
Dr. Clive S. Zent's NPI number is 1225015662. It was assigned on December 28, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Clive S. Zent?
Dr. Clive S. Zent is a hematology (internal medicine) physician in Rochester, New York. The primary specialty in the NPI Registry is Hematology (Internal Medicine) Physician (taxonomy code 207RH0000X).
Where does Dr. Clive S. Zent practice?
Dr. Zent practices at 601 Elmwood Ave, Rochester, NY 14642. Dr. Zent's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dmand AI also links Dr. Zent to 2 medical groups.
What is Dr. Clive S. Zent's office phone number?
The practice phone on file for Dr. Zent is (585) 275-2121.
What is Dr. Clive S. Zent's medical license number?
Dr. Zent's Minnesota license number on file is 45639, one of the licenses on file in 4 states.
Which states has Dr. Clive S. Zent been licensed in?
Dmand AI has state licenses on file for Dr. Zent in Minnesota (2003 to 2014), New York (2013 to 2027), Arkansas (1996 to 2003) and Illinois (1993 to 1999).
Which hospitals is Dr. Clive S. Zent affiliated with?
Dr. Zent practices at Strong Memorial Hospital in Rochester, New York.
What medical group is Dr. Clive S. Zent part of?
Dr. Zent is linked to University of Rochester Medical Faculty Group (URMFG). Dmand AI links Dr. Zent to 2 more medical groups.
Does Dr. Clive S. Zent accept Medicare?
Yes. CMS data shows Dr. Zent billed Medicare for 415 services in 2024, and Dr. Zent accepts Medicare assignment.
How many Medicare patients does Dr. Clive S. Zent see?
CMS counts 131 Medicare patients who saw Dr. Zent in 2024, with an average age of 74.
Show 9 more questionsShow fewer questions
Is Dr. Clive S. Zent board certified?
Yes. Dr. Zent is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Clive S. Zent bill to Medicare?
In 2024, Dr. Zent's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and office visit, established patient (99214).
Where did Dr. Clive S. Zent go to medical school?
Dr. Zent graduated from University of the Witwatersrand in 1983.
What drugs does Dr. Clive S. Zent prescribe most?
In 2024 Medicare Part D data, Dr. Zent's most prescribed drugs by claims were Brukinsa, Calquence and Imbruvica.
Has Dr. Clive S. Zent received payments from drug or device companies?
CMS Open Payments shows $123 in general payments to Dr. Zent from 2 companies from 2016 to 2021. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Clive S. Zent been practicing?
Dr. Zent graduated from medical school in 1983, 43 years ago.
Does Dr. Clive S. Zent do research?
Dmand AI links 183 publications to Dr. Zent, published from 2002 to 2024. Dr. Zent has worked on 6 clinical trials.
Who does Dr. Clive S. Zent publish with?
Dr. Zent's most frequent co-authors are Tait D. Shanafelt, MD (42 shared papers), Paul Michael Barr, MD (28 shared papers) and Timothy George Call, MD (21 shared papers).
What insurance does Dr. Clive S. Zent accept?
Dr. Zent is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
Selling to internal medicine practices?
See hematology (internal medicine) physicians in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card